RAPP
Rapport Therapeutics
RAPP
RAPP
55 hedge funds and large institutions have $582M invested in Rapport Therapeutics in 2024 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
2% less capital invested
Capital invested by funds: $593M → $582M (-$11.6M)
Holders
55
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$25.5M | |
| 2 | +$11.8M | |
| 3 | +$10.3M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.94M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.13M |
Top Sellers
| 1 | -$8.14M | |
| 2 | -$6.41M | |
| 3 | -$2.72M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.04M |
| 5 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
-$1.63M |